scholarly article | Q13442814 |
P50 | author | Hermona Soreq | Q15989736 |
Nurcan Üçeyler | Q109819813 | ||
Josef Bednařík | Q43875899 | ||
Heike L Rittner | Q57077845 | ||
Alexandre Favereaux | Q60398646 | ||
Michaela Kress | Q64496671 | ||
Claudia Sommer | Q64762189 | ||
Marzia Malcangio | Q39184027 | ||
P2093 | author name string | Florian Kronenberg | |
David Greenberg | |||
Zlatko Trajanoski | |||
Alexander Hüttenhofer | |||
Marc Landry | |||
Frank Birklein | |||
Rohini Kuner | |||
Peter Mouritzen | |||
Paul Heppenstall | |||
P2860 | cites work | Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome | Q24236806 |
Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain | Q24594587 | ||
Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor | Q24603928 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene | Q24620790 | ||
The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions | Q24656489 | ||
Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules | Q26997097 | ||
MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS | Q27025394 | ||
MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
Molecular targeting of NOX4 for neuropathic pain after traumatic injury of the spinal cord | Q27863429 | ||
Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy | Q28266524 | ||
MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase | Q28267386 | ||
L-type calcium channels and NMDA receptors: a determinant duo for short-term nociceptive plasticity | Q79619271 | ||
An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway | Q81813191 | ||
Expression of spinal cord microRNAs in a rat model of chronic neuropathic pain | Q82789516 | ||
Complex regional pain syndrome: A loss of inhibition? | Q83386507 | ||
Exploiting the therapeutic potential of microRNAs in human cancer | Q83459286 | ||
MicroRNA changes in the mouse prefrontal cortex after inflammatory pain | Q83598221 | ||
Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms | Q84016180 | ||
microRNA changes in the dorsal horn of the spinal cord of rats with chronic constriction injury: A TaqMan® Low Density Array study | Q85355099 | ||
Nerve injury-induced upregulation of miR-21 in the primary sensory neurons contributes to neuropathic pain in rats | Q86763294 | ||
The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets | Q28297385 | ||
Striatal microRNA controls cocaine intake through CREB signalling | Q28397558 | ||
Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132 | Q28510360 | ||
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain | Q28572461 | ||
Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression | Q28579783 | ||
Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain | Q28741963 | ||
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment | Q30458126 | ||
Genome-wide association study reveals three susceptibility loci for common migraine in the general population | Q30501682 | ||
Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target | Q30531086 | ||
Neurobiology of migraine. | Q33186891 | ||
Changes in brain MicroRNAs contribute to cholinergic stress reactions. | Q33596600 | ||
Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. | Q33716248 | ||
Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain | Q33831886 | ||
Clinical features and pathophysiology of complex regional pain syndrome | Q33906895 | ||
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity | Q33939152 | ||
Non-coding RNAs: hope or hype? | Q33986629 | ||
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease | Q34049272 | ||
Treatment of complex regional pain syndrome: a review of the evidence | Q34091375 | ||
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision | Q34110857 | ||
Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling | Q34231769 | ||
Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis | Q34299158 | ||
Morphine regulates dopaminergic neuron differentiation via miR-133b | Q34309942 | ||
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits | Q34502699 | ||
MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. | Q34606028 | ||
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. | Q34644199 | ||
Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. | Q34673364 | ||
Pharmacologic management of neuropathic pain: evidence-based recommendations | Q34699259 | ||
Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents? | Q34956293 | ||
Painful neuropathies | Q35539595 | ||
MicroRNA modulation in complex regional pain syndrome | Q35587100 | ||
Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons | Q35697823 | ||
RNA regulation: a new genetics? | Q35766845 | ||
Regulation of μ-opioid type 1 receptors by microRNA134 in dorsal root ganglion neurons following peripheral inflammation | Q39302113 | ||
Growth factors stimulate expression of neuronal and glial miR-132. | Q39452910 | ||
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. | Q39559308 | ||
Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells | Q39882902 | ||
Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways | Q39975165 | ||
Differential expression of cytokines in painful and painless neuropathies | Q40198239 | ||
GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization | Q40558217 | ||
MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structure | Q41228757 | ||
Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors | Q41509624 | ||
Changes in expression of sensory organ-specific microRNAs in rat dorsal root ganglia in association with mechanical hypersensitivity induced by spinal nerve ligation | Q41850114 | ||
Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome | Q41879388 | ||
Enhanced quantal release of excitatory transmitter in anterior cingulate cortex of adult mice with chronic pain | Q42132218 | ||
Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain | Q42136557 | ||
Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier | Q42148024 | ||
Abnormalities in hippocampal functioning with persistent pain. | Q42182780 | ||
Impairment of GABAB receptor dimer by endogenous 14-3-3ζ in chronic pain conditions | Q42260299 | ||
The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain | Q42470459 | ||
Heritability of chronic pain in 2195 extended families | Q42636486 | ||
Differential expression of microRNAs in mouse pain models | Q42700085 | ||
Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs | Q44326528 | ||
The miRNA and mRNA changes in rat hippocampi after chronic constriction injury | Q44425305 | ||
Pain-related fear, perceived harmfulness of activities, and functional limitations in complex regional pain syndrome type I. | Q44883370 | ||
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease | Q45818066 | ||
Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats | Q46270029 | ||
Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. | Q48033703 | ||
MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. | Q48859256 | ||
Pain: Molecular mechanisms | Q48935879 | ||
NeurimmiRs: microRNAs in the neuroimmune interface | Q48965771 | ||
Traumatic peripheral nerve injuries: epidemiological findings, neuropathic pain and quality of life in 158 patients | Q49130861 | ||
Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. | Q50436500 | ||
Chronic pain patients are impaired on an emotional decision-making task. | Q51002164 | ||
Economic burden of chronic pain. | Q51146531 | ||
Altered hippocampal long-term potentiation after peripheral nerve injury in mice. | Q51972138 | ||
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. | Q53318898 | ||
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis. | Q53320268 | ||
A key role for gp130 expressed on peripheral sensory nerves in pathological pain. | Q53363192 | ||
Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases. | Q54257764 | ||
Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. | Q54447471 | ||
Transcriptional and functional profiles of voltage-gated Na+ channels in injured and non-injured DRG neurons in the SNI model of neuropathic pain | Q57990405 | ||
Hematopoietic colony–stimulating factors mediate tumor-nerve interactions and bone cancer pain | Q60678255 | ||
Differential expression patterns of cytokines in complex regional pain syndrome | Q60678867 | ||
miRNA pharmacogenomics: the new frontier for personalized medicine in cancer? | Q38059508 | ||
Bioinformatics, non-coding RNAs and its possible application in personalized medicine | Q38078845 | ||
MicroRNA-143 expression in dorsal root ganglion neurons | Q38330642 | ||
Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds | Q38341734 | ||
Knockdown of L calcium channel subtypes: differential effects in neuropathic pain. | Q38347124 | ||
MicroRNA-182 regulates amygdala-dependent memory formation | Q38455718 | ||
Patterns of pain: meta-analysis of microarray studies of pain | Q38502374 | ||
Genetic evidence for an essential role of neuronally expressed IL-6 signal transducer gp130 in the induction and maintenance of experimentally induced mechanical hypersensitivity in vivo and in vitro. | Q38765969 | ||
MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. | Q39176725 | ||
Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors | Q39224411 | ||
Increased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury. | Q39271832 | ||
Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. | Q39287505 | ||
??? | Q24632313 | ||
Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. | Q35769711 | ||
MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain | Q35801416 | ||
Pain sensitivity and opioid analgesia: a pharmacogenomic twin study | Q36040669 | ||
MicroRNA-124 as a novel treatment for persistent hyperalgesia | Q36161510 | ||
Long-term, efficient inhibition of microRNA function in mice using rAAV vectors | Q36169589 | ||
miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression | Q36197696 | ||
Discovering the first microRNA-targeted drug | Q36353486 | ||
The principles of guiding by RNA: chimeric RNA-protein enzymes | Q36452595 | ||
MicroRNA-mediated GABA Aα-1 receptor subunit down-regulation in adult spinal cord following neonatal cystitis-induced chronic visceral pain in rats | Q36503179 | ||
MicroRNA 339 down-regulates μ-opioid receptor at the post-transcriptional level in response to opioid treatment | Q36534353 | ||
Inflammation in complex regional pain syndrome: a systematic review and meta-analysis | Q36659427 | ||
Understanding LTP in pain pathways | Q36779734 | ||
A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions | Q37062479 | ||
A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons | Q37092389 | ||
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine | Q37249048 | ||
P2X4R+ microglia drive neuropathic pain | Q37256253 | ||
Using hippocampal microRNA expression differences between mouse inbred strains to characterise miRNA function | Q37371867 | ||
Mode of action of cytokines on nociceptive neurons | Q37416067 | ||
Models and mechanisms of hyperalgesia and allodynia | Q37431137 | ||
Current challenges in glia-pain biology | Q37617623 | ||
Lost in the space of bioinformatic tools: a constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox | Q37645064 | ||
Anti-inflammatory treatment of Complex Regional Pain Syndrome | Q37778613 | ||
Central mechanisms of pathological pain | Q37800357 | ||
MicroRNA regulation of neural plasticity and memory | Q37869602 | ||
Complex regional pain syndrome in adults | Q37895404 | ||
Diabetic neuropathy: cellular mechanisms as therapeutic targets | Q37930962 | ||
Emerging role of microglial kinin B1 receptor in diabetic pain neuropathy | Q37966492 | ||
Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression | Q37969889 | ||
Deconstructing the neuropathic pain phenotype to reveal neural mechanisms | Q37988158 | ||
Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathy | Q37991990 | ||
Nerve injuries sustained during warfare: part I--Epidemiology | Q37995548 | ||
Pain genetics: past, present and future | Q37998675 | ||
Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases | Q38018832 | ||
Let-7 microRNAs and Opioid Tolerance | Q38022011 | ||
Twin studies of pain | Q38028613 | ||
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach | Q38053268 | ||
Epigenomics and interindividual differences in drug response | Q38055065 | ||
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 33 | |
P577 | publication date | 2013-10-17 | |
P1433 | published in | Frontiers in Molecular Neuroscience | Q27721913 |
P1476 | title | microRNAs in nociceptive circuits as predictors of future clinical applications | |
P478 | volume | 6 |
Q45876878 | Circulating microRNA Signatures in Rodent Models of Pain |
Q40523625 | Computational functional genomics based analysis of pain-relevant micro-RNAs. |
Q90707647 | Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment |
Q31163067 | Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry |
Q27023688 | Epigenetic mechanisms of chronic pain |
Q26998380 | Epigenetic regulation of persistent pain |
Q47136766 | Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma. |
Q35786420 | Expression changes of microRNA-1 and its targets Connexin 43 and brain-derived neurotrophic factor in the peripheral nervous system of chronic neuropathic rats |
Q47566382 | From Mechanism to Cure: Renewing the Goal to Eliminate the Disease of Pain |
Q35665389 | Ionizing radiation-induced microRNA expression changes in cultured RGC-5 cells |
Q50989062 | MicroRNA profiling in migraine without aura: pilot study. |
Q48654937 | MicroRNA-1-associated effects of neuron-specific brain-derived neurotrophic factor gene deletion in dorsal root ganglia. |
Q26744408 | MicroRNA: Small RNA mediators of the brains genomic response to environmental stress |
Q33810656 | Novel roles of non-coding brain RNAs in health and disease. |
Q39374230 | Pain in ankylosing spondylitis: a neuro-immune collaboration. |
Q41936990 | Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders. |
Q37577709 | Recent advances in understanding neuropathic pain: glia, sex differences, and epigenetics |
Q35430578 | Role of MicroRNA in Visceral Pain. |
Q58700931 | Second edition of SIMPAR's "Feed Your Destiny" workshop: the role of lifestyle in improving pain management |
Q33960330 | Sources of individual variability: miRNAs that predispose to neuropathic pain identified using genome-wide sequencing |
Q41714041 | Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway |
Q55315782 | The Regulatory Mechanisms and Therapeutic Potential of MicroRNAs: From Chronic Pain to Morphine Tolerance. |
Q91866937 | Tissue Specific Reference Genes for MicroRNA Expression Analysis in a Mouse Model of Peripheral Nerve Injury |
Q85891908 | [Neuropathic pain. How to open the blackbox] |
Q46902619 | miRNAs: Important Targets for Oral Cancer Pain Research |
Q38827929 | microRNA profiling in atherosclerosis, diabetes, and migraine. |
Search more.